STOCKSCOPE

Centaurus Metals (ASX: CTM) Locks In US$900 Million Nickel Sales Opportunity, but Can It Fund Jaguar?

Alison Elzayed

Alison Elzayed

Business & Finance Writer | StockScope

Published:28 Oct 2026
Centaurus Metals (ASX: CTM) Locks In US$900 Million Nickel Sales Opportunity, but Can It Fund Jaguar?

Securing buyers for an entire mine's first five years of production is a major milestone, particularly when those customers also commit US$40 million in strategic funding. For Centaurus Metals Limited (ASX: CTM), new agreements with Glencore and CNGR could bring its Jaguar Nickel Project in Brazil closer to construction.

The bigger question is whether these commitments can unlock the remaining capital required to turn Jaguar into a profitable nickel operation.

Key numbers

  • US$900 million: Estimated net sales value of two new five-year offtake agreements at current nickel prices.
  • US$40 million: Combined strategic equity commitments from Glencore and CNGR.
  • 100%: Forecast Jaguar nickel concentrate production contracted for the first five operating years.
  • 22,500 tonnes: Approximate annual nickel production covered by the offtake arrangements.
  • US$380 million: Estimated pre-production development capital under the May 2025 project optimisation study.

The latest development: Major customers back Jaguar

Centaurus announced on 28 October 2026 that Glencore and battery materials producer CNGR had signed binding agreements to purchase nickel concentrate from Jaguar.

Each new agreement covers at least 100,000 dry metric tonnes of concentrate over five years, with deliveries expected to commence in the first half of 2029.

Together with an existing Glencore contract, the arrangements cover all forecast concentrate production during Jaguar's first five operating years.

Importantly, the US$900 million headline represents estimated future sales rather than guaranteed revenue or cash received.

Actual proceeds will depend on deliveries, London Metal Exchange nickel prices and contractual payability arrangements.

Both strategic partners will subscribe for Centaurus shares at A$0.425 each, representing a 5% premium to the preceding 20-day volume-weighted average price.

The funding is structured in two tranches, with the second US$15 million conditional on shareholder approval and a final investment decision.

CNGR's participation also requires Chinese outbound investment approval.

What stands out to us

We think the most consequential aspect is the potential improvement in Jaguar's financing prospects.

Long-term sales agreements with established international counterparties reduce marketing uncertainty and could strengthen negotiations with lenders.

However, Centaurus has not secured the entire construction funding package.

The project's May 2025 optimisation study estimated pre-production capital expenditure of US$380 million, substantially exceeding the new equity commitment.

The study also outlined a post-tax net present value of US$735 million, using an 8% discount rate, and a post-tax internal rate of return of 34%.

Those figures indicate potentially attractive economics under the study's assumptions, but remain sensitive to nickel prices, operating costs and construction expenditure.

At approximately A$0.375 before the announcement, Centaurus carried a market capitalisation near A$215 million.

The apparent discount to modelled project value is substantial, although funding risk, development delays and future dilution complicate that comparison.

What the company is doing now

Centaurus is advancing Jaguar towards a final investment decision while negotiating senior project debt.

Recent milestones include securing approval for a high-voltage electricity connection and executing a power transmission agreement.

The company is also progressing its Boi Novo copper-gold exploration project, where more than 20 drill-ready targets have been identified.

While Boi Novo provides longer-term exploration optionality, Jaguar remains the principal driver of Centaurus' near-term commercial value.

Insight: Does Full Offtake Coverage Make Jaguar Financeable?

We think the Glencore and CNGR agreements represent meaningful commercial validation rather than simply another development announcement. Securing established customers for forecast production improves Jaguar's credibility, while strategic equity commitments demonstrate financial backing beyond conventional offtake arrangements.

Nevertheless, Centaurus remains exposed to nickel price volatility, substantial construction costs and unresolved debt financing. The project's projected economics look attractive, but a feasibility valuation is not equivalent to realised shareholder value.

Our assessment would strengthen considerably once binding debt facilities and a fully funded construction budget are established.

What happens next?

The immediate catalyst is completion of Jaguar's senior debt financing and a final investment decision.

Shareholder approval and satisfaction of the second equity tranche conditions must occur before the 31 January 2027 deadline.

Beyond financing, execution against the construction schedule and planned 2029 concentrate deliveries will become increasingly important.

Centaurus has substantially reduced its customer and marketing risks. The decisive test now is whether it can secure affordable construction finance and deliver Jaguar at costs consistent with its projected economics.

That distinction will determine whether today's substantial commercial commitments translate into sustainable financial value.

Alison Elzayed

Alison Elzayed

(Business & Finance Writer | StockScope)

Alison Elzayed is an experienced business and financial writer with more than 10 years of experience in the publishing industry, having previously worked as an author with Bloomsbury Publishing, specialising in business and finance. Throughout her career, Alison has developed a strong understanding of financial markets, corporate developments, economic trends and investment-related topics. Her background in financial publishing has equipped her with the ability to research complex subjects and communicate them in a clear, accurate and engaging manner.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore
Market Briefings
Market Briefings

ASX Weathers Wall Street's AI Rout, but Three Market Risks Are Becoming Harder to Ignore

Australian equities: what moved the ASX 200? Australian shares finished lower on Friday, 6 November, as the technology-led sell-off on Wall Street spread across global markets. The ASX 200...

Mark ElzayedMark Elzayed•
Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test
Biotech & Health
Biotech & Health

Epiminder (ASX: EPI) Expands FDA Clearance as $65 Million Cash Reserve Faces a Crucial Commercial Test

Epiminder Limited ASX: EPI has expanded the US market for its epilepsy monitoring technology following a significant regulatory clearance, strengthening its commercial prospects ahead of a p...

Danny AadDanny Aad•
Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?
Mining
Mining

Asara Resources (ASX: AS1) Hits 38m at 2.1g/t Gold: Could Sogosogoba Unlock Kada's Next Growth Phase?

A 38-metre gold intersection grading 2.1 grams per tonne has given Asara Resources Limited ASX: AS1 an encouraging exploration result beyond its established Massan deposit in Guinea. The dis...

Alison ElzayedAlison Elzayed•
Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?
Mining
Mining

Alvo Minerals (ASX: ALV) Expands Rare Earth Discovery Across 6.5km², but Can It Deliver Economic Value?

Alvo Minerals Limited ASX: ALV has extended rare earth mineralisation approximately 2 kilometres beyond previously tested areas at its Boa Vista prospect in Brazil, strengthening the explora...

Alison ElzayedAlison Elzayed•
Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet
Mining
Mining

Avenira Limited (ASX: AEV) Raises $48.9 Million as Wonarah Phosphate Project Faces Its Biggest Test Yet

Avenira Limited ASX: AEV has reached a significant financing milestone, with its $48.9 million rights issue providing fresh capital to advance the Wonarah Phosphate Project in the Northern T...

Alison ElzayedAlison Elzayed•
Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?
Biotech & Health
Biotech & Health

Mayne Pharma Group (ASX: MYX) Unveils $55.5 Million Sale, but Can Its US Business Deliver Stronger Profits?

Mayne Pharma Group Limited ASX: MYX is taking a decisive step towards becoming a US-focused pharmaceutical company, agreeing to sell its international operations for $55.5 million. The tran...

Danny AadDanny Aad•
Loading more stories...